APA (7th ed.) Citation

Napolitano, V., Dabrowska, A., Schorpp, K., Mourão, A., Barreto-Duran, E., Benedyk, M., . . . Pyrc, K. (2022). Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. Cell chemical biology, 29(5), 774-784.e8. https://doi.org/10.1016/j.chembiol.2021.11.006

Chicago Style (17th ed.) Citation

Napolitano, Valeria, et al. "Acriflavine, a Clinically Approved Drug, Inhibits SARS-CoV-2 and Other Betacoronaviruses." Cell Chemical Biology 29, no. 5 (2022): 774-784.e8. https://doi.org/10.1016/j.chembiol.2021.11.006.

MLA (9th ed.) Citation

Napolitano, Valeria, et al. "Acriflavine, a Clinically Approved Drug, Inhibits SARS-CoV-2 and Other Betacoronaviruses." Cell Chemical Biology, vol. 29, no. 5, 2022, pp. 774-784.e8, https://doi.org/10.1016/j.chembiol.2021.11.006.